acyclovir sodium

Generic: acyclovir sodium

Labeler: eugia us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir sodium
Generic Name acyclovir sodium
Labeler eugia us llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

acyclovir sodium 500 mg/10mL

Manufacturer
Eugia US LLC

Identifiers & Regulatory

Product NDC 55150-154
Product ID 55150-154_410e306b-e8b9-4ff5-b703-a3005eec272f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203701
Listing Expiration 2026-12-31
Marketing Start 2013-10-11

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55150154
Hyphenated Format 55150-154

Supplemental Identifiers

RxCUI
1734932 1734934
UPC
0355150155200 0355150154104
UNII
927L42J563

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir sodium (source: ndc)
Generic Name acyclovir sodium (source: ndc)
Application Number ANDA203701 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 500 mg/10mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-10) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

55150-154-10 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-10) / 10 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

acyclovir sodium (500 mg/10mL)

Linked Drug Pages (2)

Acyclovir Sodium ndc-match (0.9) Acyclovir Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "410e306b-e8b9-4ff5-b703-a3005eec272f", "openfda": {"upc": ["0355150155200", "0355150154104"], "unii": ["927L42J563"], "rxcui": ["1734932", "1734934"], "spl_set_id": ["ae921e4e-b8ae-4a45-acc1-32e5e719812b"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-10)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-154-10", "marketing_start_date": "20131011"}], "brand_name": "Acyclovir Sodium", "product_id": "55150-154_410e306b-e8b9-4ff5-b703-a3005eec272f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "55150-154", "generic_name": "Acyclovir Sodium", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir Sodium", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "500 mg/10mL"}], "application_number": "ANDA203701", "marketing_category": "ANDA", "marketing_start_date": "20131011", "listing_expiration_date": "20261231"}